Combination of peripheral blood gene expression profiles and clinical parameters predicts response for tocilizumab (anti-IL6) treatment in rheumatoid arthritis

Export Metadata as DATS

Peripheral blood samples were obtained at week 0 and week 4 of tocilizumab treatment and global gene expression profiling identified markers of responder status.

Project

Project Title: Combination of peripheral blood gene expression profiles and clinical parameters predicts response for tocilizumab (anti-IL6) treatment in rheumatoid arthritis
Project website: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA134351

Datasets

Combination of peripheral blood gene expression profiles and clinical parameters predicts response for tocilizumab (anti-IL6) treatment in rheumatoid arthritis

Study description

Primary Purpose: -
Description of Cohorts: -
Informed Consent Given?: -
Multi-center Study?: -

Subjects

Organisms: Homo sapiens
Number of subjects: -
Diseases: rheumatoid arthritis
Sample Sources: -
Type of Samples Collected: -

Demographic and Participant Information